February 17, 2010 (Paris, France) — A new-point-of care test that can be used in the cath lab to monitor anticoagulation levels of enoxaparin (Lovenox, Sanofi-Aventis) has been shown to give reliable ...
"Is this the end of UFH? We continue to have more and more evidence suggesting better and safer outcomes with low-molecular-weight heparin, and we as interventionalists should pay attention to this." ...
Study Overview: AstraZeneca is running a Phase I study titled “A Phase I, Randomized, Single-blind, Placebo-controlled Study to Further Characterize Andexanet Posology and Assess the Interaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results